LXEO - Lexeo Therapeutics, Inc. Common Stock -  [ ]

Seasonality of Returns By Period

Average daily return by calendar bucket (ClosePriceSA).

Day of Week

Week of Month

Month of Year

Seasonal Path

YTD vs Last Year vs Lookback Avg ยท closes rebased to 100 at each year's first session
Ticker Details
Lexeo Therapeutics, Inc. Common Stock
IPO Date: November 3, 2023
Sector: Healthcare
Industry: Biotech
Market Cap: $344.59M
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.35 | 4.44%
Avg Daily Range (30 D): $0.13 | 2.71%
Avg Daily Range (90 D): $0.19 | 3.95%
Institutional Daily Volume
Avg Daily Volume: .53M
Avg Daily Volume (30 D): .69M
Avg Daily Volume (90 D): .72M
Trade Size
Avg Trade Size (Sh.): 96
Avg Trade Size (Sh.) (30 D): 100
Avg Trade Size (Sh.) (90 D): 89
Institutional Trades
Total Institutional Trades: 305
Avg Institutional Trade: $1.56M
Avg Institutional Trade (30 D): $1.08M
Avg Institutional Trade (90 D): $1.29M
Avg Institutional Trade Volume: .2M
Avg Institutional Trades (Per Day): 1
Market Closing Trades
Avg Closing Trade: $1.65M
Avg Closing Trade (30 D): $1.18M
Avg Closing Trade (90 D): $1.08M
Avg Closing Volume: 215.54K
 
News
Jan 12, 2026 @ 12:00 PM
Lexeo Therapeutics Announces Positive Interim Phas...
Source: Na
Jan 8, 2026 @ 12:00 PM
Lexeo Therapeutics Announces Research Collaboratio...
Source: Na
Oct 17, 2025 @ 3:29 AM
Lexeo Therapeutics Announces Pricing of Public Off...
Source: Lexeo Therapeutics
Oct 7, 2025 @ 10:00 AM
Lexeo Therapeutics Announces Progress in FDA Discu...
Source: Lexeo Therapeutics
Apr 7, 2025 @ 10:00 AM
Lexeo Therapeutics Announces Positive Interim Phas...
Source: Lexeo Therapeutics
Financials
  TTM Q2 2026 Q1 2026
Basic EPS $-1.02 $-.3 $-.25
Diluted EPS $-1.02 $-.3 $-.25
Revenue $M $M $M
Gross Profit
Net Income / Loss $-87.27M $-25.87M $-20.2M
Operating Income / Loss $-95.12M $-28.02M $-22.33M
Cost of Revenue
Net Cash Flow $57.35M $21.07M $8.77M
PE Ratio